Publication:
Dietary Supplementation with Low-Dose Omega-3 Fatty Acids Reduces Salivary Tumor Necrosis Factor-α Levels in Patients with Chronic Periodontitis: A Randomized Controlled Clinical Study

dc.authorscopusid14054138800
dc.authorscopusid56095234800
dc.authorscopusid8142040400
dc.authorscopusid35591227100
dc.authorscopusid6603698171
dc.contributor.authorKeskiner, I.
dc.contributor.authorSaygun, I.
dc.contributor.authorBal, V.
dc.contributor.authorSerdar, M.
dc.contributor.authorKantarci, A.
dc.date.accessioned2020-06-21T13:18:53Z
dc.date.available2020-06-21T13:18:53Z
dc.date.issued2017
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Keskiner] Ilker, Department of Periodontology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Saygun] Işil, Department of Periodontology, Gülhane Eğitim ve Araştırma Hastanesi, Ankara, Turkey; [Bal] Vehbi, Department of Periodontology, Gülhane Eğitim ve Araştırma Hastanesi, Ankara, Turkey; [Serdar] Muhittin A., Department of Medical Biochemistry, Acıbadem Mehmet Ali Aydınlar Üniversitesi, Istanbul, Turkey; [Kantarci] Alpdoǧan I., Department of Periodontology, Forsyth Institute, Boston, MA, United Statesen_US
dc.description.abstractBackground and Objective: Recent studies have demonstrated the beneficial effects of omega-3 polyunsaturated fatty acids (PUFAs) on physiological processes and on a variety of chronic inflammatory diseases, including periodontal diseases. In this study, we evaluated the impact of omega-3 PUFAs in conjunction with scaling and root planing (SRP) on salivary markers in patients with chronic periodontitis. Material and Methods: Thirty systemically healthy subjects with chronic periodontitis were enrolled and randomly allocated into two groups. The control group (n = 15) was treated with SRP + placebo whereas the test group was treated with SRP and dietary supplementation of low-dose omega-3 PUFAs (6.25 mg eicosapentaenoic acid and 19.19 mg docosahexaenoic acid). Clinical parameters were taken at baseline, 1, 3 and 6 mo following therapy. Saliva samples were obtained at the same time intervals and analyzed for tumor necrosis factor-α (TNF-α) and superoxide dismutase (SOD). Results: Both groups showed significant changes in clinical parameters in response to treatment compared to baseline with no significant difference between groups. Salivary TNF-α levels showed a statistically significant decrease in the test group at 6 mo compared to the control group. Salivary SOD levels increased significantly at 3 and 6 mo in the test group and at 6 mo in placebo groups compared to baseline with no statistically significant differences between the groups. Conclusion: The results demonstrated that dietary supplementation with low-dose omega-3 PUFAs improves salivary TNF-α without any significant impact on clinical parameters in patients with chronic periodontitis, suggesting that the systemic benefits of dietary omega-3 PUFAs may not be translated to periodontal health. (ClinicalTrials.gov ID NCT02719587). © 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltden_US
dc.identifier.doi10.1111/jre.12434
dc.identifier.endpage703en_US
dc.identifier.issn0022-3484
dc.identifier.issn1600-0765
dc.identifier.issue4en_US
dc.identifier.pmid28177133
dc.identifier.scopus2-s2.0-85013025284
dc.identifier.scopusqualityQ1
dc.identifier.startpage695en_US
dc.identifier.urihttps://doi.org/10.1111/jre.12434
dc.identifier.urihttps://hdl.handle.net/20.500.12712/12348
dc.identifier.volume52en_US
dc.identifier.wosWOS:000406981400004
dc.identifier.wosqualityQ1
dc.language.isoenen_US
dc.publisherBlackwell Munksgaard info@mks.blackwellpublising.comen_US
dc.relation.ispartofJournal of Periodontal Researchen_US
dc.relation.journalJournal of Periodontal Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChronic Periodontitisen_US
dc.subjectOmega-3en_US
dc.subjectSalivaen_US
dc.subjectTumor Necrosis Factor-αen_US
dc.titleDietary Supplementation with Low-Dose Omega-3 Fatty Acids Reduces Salivary Tumor Necrosis Factor-α Levels in Patients with Chronic Periodontitis: A Randomized Controlled Clinical Studyen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files